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Children are more susceptible to medication errors because of differences in pharmaco-
kinetics and pharmacodynamics compared to adults. Weight changes are common with
growth in children and computer systems frequently are not updated with current infor-
mation, which result in inaccurate weight-based dosing and thus harm children. This
study evaluated the impact of a Computerized Physician Order Entry system with stan-
dardized pediatric dosing decision support (PDDS) function on reducing pediatric dosing
errors. Outpatient prescriptions were analyzed from January to March during 2010 and
2011. The total number of pediatric prescriptions was 72,431 and 80,532 prior to and after
system implementation, respectively. Out of 72,431 prescriptions, 1617 (2.23%) dosing er-
rors were retrospectively detected by the system, whereas 15 dosing errors (0.02%) were
detected by pharmacists prior to system implementation. Incorporating the system into
practice resulted in a total of 210 successfully blocked dosing near misses, including 14
potentially fatal and 11 serious near misses. The final dosing error rate was significantly
reduced from 2.23% to 0.66% ( p < 0.001). A 10-fold increase of the near miss correction rate
(0.02% vs. 0.26%, p < 0.001) was observed. The Computerized Physician Order Entry system
with standardized pediatric dosing decision support system provided real-time warning
and significantly decreased the dose error rate among pediatric patients.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.acy, Taipei Medical University eWan Fang Hospital, No. 111, Section 3, Hsing Long Road,
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j o u r n a l o f f o o d and d ru g an a l y s i s 2 1 ( 2 0 1 3 ) 2 8 6e2 9 1 2871. Introduction outpatient setting. Data were compared between systems thatTable 1 e Medications listed in the database of the
pediatric dosing decision support (PDDS) system.
Class Medications
Analgesics Acetaminophena, ketoralac, celecoxib,
diclofenac, mefenamic acid, meloxicam
Antibiotics Amoxicillina, ceftibuten, cefaclor, ampicillin,
ciprofloxacin, cephalexina, cefuroximea,
doxymycin, nalidixic acid, minocycline,
azithromycina, clindamycin, erythromycina,
ethambutol, clarithromycin, tetracycline,
mebendazole, rifampicin, fluconazole,
metronidazole, ketoconazole, itraconazolea,
terbinafine, tinidazole, famciclovir, ribavirin,
pyrantel, oseltamivir, neomycin,
sultamicillin, sulfamethoxazole/
trimethoprima
Antiepileptic drugs Carbamazepinea, phenobarbital,
valproic acida, phenytoin, levetiracetama,
gabapentin, topiramate, lamotrigine,
vigabatrin
Respiratory/allergy
medications
Acetylcysteine, dextromethorphan,
cetirizinea, prednisolonea, aminophylline,
dexchlorpheniramine, hydroxyzine,
procaterola, theophyllinea, fexofenadine,Potentially harmful medication errors are three times more
likely to occur in children than in adults [1]. Medication dosing
errors are among the most common types of pediatric medi-
cation errors and near misses[2e4]. Pediatric dosing is pre-
scribed on the basis of body weight and age, and thus prone to
calculation errors, particularly among newborns with rapid
growth.Anunderdose canoccur amongchildren if theirweight
is not confirmed at each visit. In addition, an overdose may
occur if a dose of medication is given without accurate calcu-
lation[5]. Most pharmaceutical companies only develop medi-
cations for adults. If a medication is not available in pediatric
dosage, clinicians have to make dose adjustments by cutting
pills or extemporaneous compounding for pediatric patients.
Children are rarely included in pre-marketing clinical trials;
thus dosages and adverse reactions for them are not compre-
hensively understood. Such factorsmake childrenmore prone
to medication dosing errors and unexpected side effects.
Manyhospitalshaveworkedon improvingmedicationsafety
since reports on pediatric medication errors were released by
the Institute of Medicine of the National Academies of the
United States and the American Academy of Pediatrics[5e8].
Some pioneering studies have reported on the contribution of
Computerized Physician Order Entry (CPOE) used in reducing
pediatric medication errors[6,9e13]. Holdsworth et al [14] re-
ported that adverse reaction events in the pediatric intensive
care unit and on the general wardswere reduced and prevented
by the implementation of CPOE. Even a simple computerized
alert to remind clinicians of re-entering patient bodyweight has
significantly reducedmedicationdosing errors [15]. Corderoetal
[16] introduced a clinical support system for 12 medications in
the neonatal intensive care units, and the dosing error of gen-
tamycin was reduced from 13% to zero. By implementing the
CPOE system in the neonatal intensive care units and pediatric
intensive care units, prescribing errors and adverse reactions
were significantly reduced by 99.4% and 40.9%, respectively [17].
For the hospitals equipped with CPOE systems, imple-
menting a clinical support system to promote accurate
medication dose calculations might be a useful approach to
further enhance medication safety among pediatric patients.
A previous study showed that, in spite of the CPOE system
reducing general medication errors, pediatric dosing errors
were not decreased without a dose-range checking system
[18]. McPhillips et al [19] reported that the incidence of medi-
cation dosing errors (overdose or underdose) was not reduced
after the implementation of the CPOE system in the pediatric
outpatient setting. The goal of this study was to evaluate
whether pediatric dosing errors in the pediatric outpatient
setting could be effectively detected with a combination of a
CPOE and a pediatric dosing decision support (PDDS) system.
ambroxola, cyproheptadinea, albuterola,
fenoterol, mizolastine
Gastrointestinal
medications
Domperidonea
Others Mephenoxalone, hydroxychloroquin,
chloral hydratea
a Medications come with liquid form and provide convenient
dosing for pediatric patients.2. Methods
2.1. Study design
This study was conducted to evaluate the impact of a PDDS
system on pediatric medication dosing errors in a hospitalcombined PDDS built into the CPOE and the CPOE only. All
prescriptions for pediatric patients less than 18 years of age in
a medical center located in northern Taiwan were studied
from January 2011 to March 2011; they were simultaneously
assessed and documented by the CPOE and PDDS combined
system. The medications included in the PDDS system are
listed in Table 1. All prescriptions for pediatric patients less
than 18 years of age in the CPOE system only period (January
2010 to March 2010) were retrospectively analyzed by the
combined system as the control. The differences in near-miss
detection rates, initial dose error rates and final dose error
rates for medications dispensed to patients were compared
between the two groups. The physician acceptance rates of
the suggested dose were also evaluated.
2.2. Implementation of pediatric dosage computerized
system
A pediatric dosage database was established and an alerting
model was designed to interact with our existing CPOE system
to provide decision support regarding pediatric dose calcula-
tions based on age and weight. The medications, decision
logic and display screen of the databasewere determined after
an extensive discussion between pediatricians and pharma-
cists, as well as a review of the relevant medical literatures
[19]. The selection of the medications was based on
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ports [19] and modified with commonly used pediatric medi-
cations in our hospitals. Medication package inserts as well as
reference books or databasesdincluding a Pediatric Dosage
Handbook [20], the Harriet Lane Handbook [21], the CHLA Pe-
diatric Dosing Handbook and Formulary [22] and Micromedex
[23]dwere used to determine dosages. The dosage ranges
were set up according to the lowest and the highest recom-
mended dosage across all listed indications. Expert opinions
were included if there was a conflict among the literatures
reviewed. For example, the recommended dose of amoxicillin/
clavulanic acid was 25e45 mg/kg/day with a maximum at
90 mg/kg/day according to the package insert [24]. However,
the 2007 Guideline for the Management of Pediatric Pneu-
monia in Taiwan [25] and Management of Acute Otitis Media
by the American Academy of Pediatric in 2004 suggested
the use of amoxicillin at 80e90 mg/kg/day because of the
high resistance rate of Streptococcus pneumoniae and beta-
lactamases producing Haemophilus influenzae [26e29]. There-
fore, the recommended dose of amoxicillin/clavulanic acid
was set at amoxicillin 80e90 mg/kg/day in the PDDS system
after an internal discussion. The PDDS database was further
confirmed by two pharmacists and two pediatricians.
During the initial testing stage of the database, some liquid
medications for symptoms relief such as cetirizine, cypro-
heptadine, methylephedrine/chlorpheniramine and guaife-
nesin were often intentionally prescribed at lower than
recommended doses by physicians; therefore, the research
team decided to eliminate the minimum dosage requirement
for these medications. However, after eight unintentional
underdoses identified by pharmacists, theminimumdosewas
then restored after a discussion with pediatricians.
To ensure correctweight-based dosing, the CPOE and PDDS
system allowed physicians to prescribe only after the pediat-
ric patient weight was re-entered at each visit. After the
physicians prescribed the medication, the system automati-
cally checked the dose ranges according to the revised body
weight and age of the patient. Alert windows with warning
messages would remind physicians when the dosages were
lower than theminimum recommended dose, higher than the
maximum recommended dose, or outside the range of mini-
mum and maximum doses, as well as provide the recom-
mended doses established in the system. Warning alerts
continued to display until the prescribed dosewas determined
to be reasonable according to the system’s dosing database.
For medications without established dosing information in
certain pediatric age range, the database wasmaintained, and
a warning window of “the medication is not recommended in
this age group” would come up to remind the physician,
functioning like other dosage reminding warnings.
2.2.1. Definition
The “near-miss detection rate” was defined as the number of
prescriptions with dosing errors detected at the time of
dispensing by pharmacists (prior to and after PDDS) and at the
time of prescribing by real-time PDDS warnings (after PDDS)
divided by the total number of prescriptions for pediatric pa-
tients. The “near-miss blocking rate” was the number of pre-
scriptions detected and actually corrected by physicians per
pharmacists’ recommendation (prior to and after PDDS) andPDDS warnings (after PDDS) divided by the total number of
prescriptions for pediatric patients. The “initial dose error
rate” was defined as the number of prescriptions with initial
dosing errors detected by pharmacists and the system
(retrospectively prior to PDDS and prospectively after PDDS)
divided by the total number of prescriptions for pediatric pa-
tients. The “final dose error rate” was the number of pre-
scriptions with dosing errors dispensed to patients divided by
the total number of prescriptions for pediatric patients. The
“acceptance rate” was the number of prescriptions modified
by physicians after the activation of the system alerts or
pharmacists’ recommendation divided by the total number of
prescriptions with dosing errors detected by pharmacists and
the system. Therefore, the acceptance rate prior to the PDDS
system equaled to the acceptance rate to pharmacists’ rec-
ommendations. Severity [30] was classified into three cate-
gories: “fatal dosing errors” were prescriptions with doses 10
times higher than the normal dose, or higher than the
maximum dose; “serious dosing errors” occurred when the
drug dose was 4e10 times higher than the normal dose or the
drug dose was lower than the normal dose range for patients
during the acute phase of a disease; an “apparent dosing
error” occurred when the drug dose was 0.5e4 times higher
than the normal dose or the drug dose was lower than the
normal dose range for treatment of a given disease. “Under-
dose” [19] was defined as a dose lower than 90% of the rec-
ommended total lowest daily dosage per kilogram of body
weight (mg/kg/day) and also lower than the minimum rec-
ommended daily dosage for adults. “Overdose” was defined as
a dose higher than 110% of the recommended total daily
highest dosage, higher than maximum dose for children, or
higher than the maximum recommended daily dosage for
adults.
2.2.2. Statistical analysis
The data were analyzed using SPSS version 16 (SPSS, Inc.,
Chicago, IL, USA). Data in this study are mainly presented as
percentages and average rates. Variables were analyzed using
the Chi-square (c2) test. A p value <0.05 for a two-sided test
was considered statistically significant.3. Results
The total number of pediatric prescriptions was 72,431 prior to
and 80,532 after the system implementation. The majority of
dosing errors occurred in pediatric patients 1e6 years of age,
followed by patients 6e12 years of age (Table 2). The PDDS
system successfully boosted the near-miss “detection rate” by
more than 40-fold, from 0.02% to 0.92%, during the two study
periods (p< 0.001) (Table 3). Prior to implementing the system,
15 medication dosing near misses were detected by pharma-
cists, including three potentially fatal errors (cetirizine, chlo-
ral hydrate, acetaminophen), one serious error (cetirizine),
and 11 apparent errors; however, 1617 dosing errors were
detected retrospectively by the system. After implementing
the system, 15 dosing near misses were detected by pharma-
cists and 740 by the system simultaneously. The system
decreased the “initial dose error rate” from 2.25% to 0.91%
(p < 0.001) (Table 3). The total near-miss “blocking” increased
Table 2 e The demographic information of pediatric
patients displayed in the warning messages.
Prior to PDDS
implementation
After PDDS
implementation
Total no. of pediatric
prescriptions
72,431 80,532
Total no. of dosing errors
detected by the system
1617 740
M 934 (57.76) 421 (56.89)
F 683 (42.24) 319 (43.11)
Newborns (<4 wk) 9 (0.55) 9 (1.22)
Infants (4 wk to 1 y old) 76 (4.70) 212 (28.65)
Young children (1e6 y old) 904 (55.91) 318 (42.97)
Children (6e12 y old) 517 (31.97) 189 (25.54)
Adolescents (12e18 y old) 111 (6.86) 12 (1.62)
Data are presented as n (%).
F ¼ female; M ¼ male; PDDS ¼ pediatric dosing decision support.
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0.26%, p < 0.001, Table 3). Among the 1632 initial dose errors,
15 errors were blocked prior to the implementation of the
PDDS system. After implementing the system, a total of 210
dosing near misses were successfully blocked and corrected
by physicians (195 by the system and 15 by pharmacists),
including 14 classified as fatal and 11 as serious. Medications
involved in potentially fatal errors included cetirizine (4
cases), acetaminophen (3 cases), amoxicillin, cephalexin,
fenoteral, fexofenadine, loratadine/pseudoephedrine, proca-
terol, and chloral hydrate. The physician acceptance rate of
pharmacist intervention and the system warning was 100%
(15/15) and 28.38% (210/740) prior to and after the imple-
mentation of PDDS system, respectively. The “final dose error
rate” decreased significantly after the system was introduced
(2.23% vs. 0.66%, p < 0.001; Table 3).
Table 4 shows the analysis of 530 dosing warnings that
were not accepted by physicians. There were 297 (56.04%)
cases of underdosing and 233 (43.96%) cases of overdosing.
The distribution of doseswas primarily in the 50e89% range of
the minimum recommended dose (52.64%). Among the pre-
scriptions that were under the appropriate dose, analgesics
accounted for 82.49% (245/297), and acetaminophen was the
most commonmedication, followed by respiratory and allergy
medications that accounted for 10.77% (32/297), of which betaTable 3 e Comparison of pediatric prescription dosing errors p
Prior t
implem
Total no. of pediatric prescriptions 72,43
No. of near misses detected by pharmacists
and system (detection rate)
15 (0
Prescriptions with initial dose errora 1632
Number of near misses blocked by pharmacists
and system in time (blocking rate)
15 (0
Prescriptions with final dose error 1617
Data are presented as n (%).
PDDS ¼ pediatric dosing decision support.
a Number of initial dose error prescriptions ¼ number of near misses de2 agonists including albuterol, procaterol, and fenoterol were
the most common. For prescriptions considered to be over-
doses, respiratory and allergy medications were the majority
(88.84%, 207/233), of which ambroxol and dextromethorphan
were the most common drugs, followed by antibiotics (6.44%,
15/233) that were dominated by the amoxicillin/clavulanic
acid solution.4. Discussion
The results of this study showed that the coupling of the CPOE
systemwith the PDDS system effectively detected nearmisses
and reduced dose prescribing errors including potentially fatal
errors. By requesting the body weight prior to prescribing, the
initial dose error rate was significantly reduced. With the
timely provision of dosage recommendations and validation
by the system, nearly one-third of prescribing near misses
were corrected, and the final dose errors of medication
dispensed to patients were further reduced. Consistent with
previous pioneering findings in the intensive care unit setting
and for limited medications [19e21,23], the present study also
demonstrated the contribution of an informatics system to
pediatric medication safety and the possibility of imple-
menting such a system in the outpatient setting with an
increased number of services and prescriptions.
The results of the present study demonstrated that the
PDDS system added substantial value in detecting and pre-
venting potential fatal errors among pediatric patients. The
pharmacists detected three potentially fatal errors prior to
implementation, including one sentinel event with a nearly
doubled prescribed dose. After the system was implemented,
14 potential fatal near misses were detected. Although it is
uncertain whether there was any change in prescribing habits
among physicians that influence the number of near misses,
the prescriptions with potentially fatal errors were mainly
unintentional errors caused by hitting the wrong numbers or
choosing the wrong product forms, such as cetirizine 10 mg/
tab versus cetirizne 1 mg/mL. With a real-time warning
message provided by the system, the PDDS system success-
fully blocked the serious and potentially fatal errors prior to
the completion of prescription order entry by physicians. In
addition, this system can also save time on the back-and-forthrior to and after PDDS system implementation.
o PDDS
entation
After PDDS
implementation
p
1 80,532
.02) 740 (0.92) <0.001
(2.25) 740 (0.92) <0.001
.02) 210 (0.26) <0.001
(2.23) 530 (0.66) <0.001
tected by pharmacists and the system.
Table 4 e The drug class distribution of final dosing errors after PDDS implementation (prescriptions with PDDS dosing
warnings NOT accepted by physicians).
Range of dosing errors
Underdoses Overdoses
Type of medication <50% 50e90% 110e200% >200% >400% N (%)
Analgesics 5 (0.94) 240 (45.28) 10 (1.87) 0 0 255 (48.11)
Antibiotics 1 (0.19) 10 (1.87) 14 (2.64) 1 (0.19) 0 26 (4.91)
Antiepileptics 2 (0.38) 0 1 (0.19) 0 0 3 (0.57)
Respiratory drugs 3 (0.57) 29 (5.47) 144 (27.17) 62 (11.70) 1 (0.19) 239 (45.09)
Gastrointestinal drugs 7 (1.32) 0 0 0 0 7 (1.32)
Total number 18 (3.40) 279 (52.64) 169 (31.89) 63 (11.89) 1 (0.19) 530 (100)
Data are presented as n (%).
PDDS ¼ pediatric dosing decision support.
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order modification.
One of the major issues identified in this study is that
commercially availablemedication dosage forms did notmeet
the current needs of children. Underdosed prescriptions were
predominated by acetaminophen, followed by the class of
beta 2 agonists in this study. Physicians tend to keep the dose
of beta 2 agonists low to avoid palpitations. However, the
available oral tablet form of acetaminophen did not provide a
convenient dosage calculation when it was prescribed to older
children as needed. Prescribing a half tablet of 500 mg acet-
aminophen, although below the recommended dosage of
300e450mg/dose for a 30-kg child, is considered a safer choice
for clinicians. In addition, a previous report indicated that
about 64% of pediatric prescriptions for acetaminophen were
underdoses [31]. Another example of limited available dosage
forms is with dextromethorphan, which is commonly pre-
scribed as one-half of a tablet for older children; however, this
resulted in doses higher than the maximum daily recom-
mendation in this study. The data suggest that collaboration
between policy makers and manufactures to produce
contemporary pediatric dosage forms is essential for pediatric
medication safety.
The 28% physician acceptance rate of the PDDS system in
this study is similar to a previously reported acceptance rate
of 32% [32]. The correction rate indicated that, despite some
medications with limited dosage forms, there were some
warning alerts ignored by physicians in this and the previous
study [32], leading to subsequent medication dosing errors.
According to Killelea et al [32], it is difficult to know what the
“ideal” acceptance rate should be, because deviations from a
CPOE-generated suggestion in many situations would be
considered medically appropriate. Several common reasons
reported in this study for ignoringwarnings other than dosage
form limitations included higher antibiotic dosing to over-
come resistance, low clinical impact on minimal overdoses,
and to avoid side effects. Even though the prescriptions with
final dose errors had no fatal dosing errors and were mostly
apparent dosing errors, further communication and constant
revising and refining of the system are necessary to resolve
this issue.
The number of near misses detected by pharmacists did
not decrease with the PDDS system implementation in thepresent study. After the PDDS system implementation, 15
near misses were detected by pharmacists, the same number
as that noted prior to when the PDDS system was imple-
mented. All of the near misses detected by pharmacists were
previously detected by the PDDS system; however, the dosage
warnings were ignored by the prescribers at the time of pre-
scribing. After a direct communication between pharmacists
and physicians, 15 prescriptions were modified with recom-
mended dosage prior to dispensing to patients. Prior to and
after the PDDS system, physician acceptance rate to phar-
macist recommendation in our study were both 100%. This
also indicated that direct communication is essential, and
that the PDDS system is not meant to replace pharmacist
double checking of the prescriptions, but rather to work as a
first-line reminder to help improve medication safety. It is
important for clinicians to recognize that the warning alerts,
although theymight seem to slow down clinical work, provide
an important function.
The limitations of this study include the following. The 3-
month duration of the monitoring period prior to and after
the system implementationmight not be able to represent the
medication errors of the entire year; however, medication
errors at the same time of each yearwere compared in order to
prevent seasonal effect on medication error rate [18], and the
pediatric prescriptions (<18 years of age) accounted for a
similar proportion of the total outpatient prescriptions in both
years (10.24% in 2010 and 10.38% in 2011). Second, although
the system requested physicians to reenter weight informa-
tion, it was unable to ensure the accuracy of the data entered.
Third, the system provided warning to the prescribers but did
not prohibit prescribing. A significant amount of inappro-
priate medication dosages were prescribed under physicians’
awareness, either to avoid side effects or were limited by
available dosage forms. Therefore, although automatically
blocking the dosing errors might not be clinically feasible at
the initial stage, PDDS still served as an important bridge for
communication between pharmacists and physicians, and
provided the information for the pharmacy to continuously
modify the system according to the needs of clinical practice
and to ensure medication safety.
In conclusion, dosing errors are common medication
mistakes in pediatric practice. By implementing the PDDS
system, real-time warnings were provided whenever an
j o u r n a l o f f o o d and d ru g an a l y s i s 2 1 ( 2 0 1 3 ) 2 8 6e2 9 1 291underdose or overdose was prescribed. The results of this
study demonstrated that the PDDS system significantly
increased near misses blocked, and decreased both initial
dose error rate and final dose error rate in pediatric
prescriptions.
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